DE122011100046I1 - In vitro kulturprozess fur verschiedene stadien von gewebeparasiten. - Google Patents

In vitro kulturprozess fur verschiedene stadien von gewebeparasiten.

Info

Publication number
DE122011100046I1
DE122011100046I1 DE201112100046 DE122011100046C DE122011100046I1 DE 122011100046 I1 DE122011100046 I1 DE 122011100046I1 DE 201112100046 DE201112100046 DE 201112100046 DE 122011100046 C DE122011100046 C DE 122011100046C DE 122011100046 I1 DE122011100046 I1 DE 122011100046I1
Authority
DE
Germany
Prior art keywords
different stages
vitro culture
culture process
tissue parasites
parasites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE201112100046
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut de Recherche pour le Developpement IRD
Original Assignee
Institut de Recherche pour le Developpement IRD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut de Recherche pour le Developpement IRD filed Critical Institut de Recherche pour le Developpement IRD
Publication of DE122011100046I1 publication Critical patent/DE122011100046I1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE201112100046 1993-05-13 2011-09-14 In vitro kulturprozess fur verschiedene stadien von gewebeparasiten. Pending DE122011100046I1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9305779A FR2705358B1 (fr) 1993-05-13 1993-05-13 Procédé de culture in vitro de différents stades de parasites tissulaires, stades parasitaires obtenus et applications biologiques.
PCT/FR1994/000577 WO1994026899A1 (fr) 1993-05-13 1994-05-13 Procede de culture in vitro de differents stades de parasites tissulaires

Publications (1)

Publication Number Publication Date
DE122011100046I1 true DE122011100046I1 (de) 2012-01-19

Family

ID=9447092

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69434424T Expired - Lifetime DE69434424T2 (de) 1993-05-13 1994-05-13 In vitro kulturprozess für verschiedene stadien von gewebeparasiten
DE201112100046 Pending DE122011100046I1 (de) 1993-05-13 2011-09-14 In vitro kulturprozess fur verschiedene stadien von gewebeparasiten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69434424T Expired - Lifetime DE69434424T2 (de) 1993-05-13 1994-05-13 In vitro kulturprozess für verschiedene stadien von gewebeparasiten

Country Status (8)

Country Link
US (4) US6458581B1 (de)
EP (1) EP0698099B1 (de)
AU (1) AU6800094A (de)
CA (1) CA2162555C (de)
DE (2) DE69434424T2 (de)
ES (1) ES2245776T3 (de)
FR (2) FR2705358B1 (de)
WO (1) WO1994026899A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9503451A (pt) * 1995-07-26 1997-09-30 Mendes Rodolfo Pereira Processo de preparação de um antígeno derivado de um mocroorganismo causador de doença infecciosa e/ou parasitária processo de preparação de um antígeno de T cruzi antígeno derivado de midroorganismo causador de doença infecciosa e/ou parasitária antígeno derivado de T cruzi causador de doença de chagas composição a base de um antígeno derivado de microorganismo causador de doença infecciosa e/ou parasitária composição a base de antígeno de T cruzi utilização do antígeno derivado de microorganismo causador de doença infecciosa e/ou parasitária em testes sorológicos e vacinas utilização de antigeno derivado de T cruzi causador de doença de chagas em teste sorológico e vacinas processo para detecção de anticorpos anti antigeno de microorganismo causador de doença infecciosa e/ou parasitária e kit para sorodiagnóstico confirmatório para doença infecciosa e/ou parasitária
FR2825633B1 (fr) * 2001-06-11 2005-12-16 Bio Veto Tests Bvt Complexe vaccinal therapeutique destine a la prevention et au traitement des leishmanioses et des infections a microorganismes pathogenes intracellulaires chez le mammifere
FR2862313B1 (fr) * 2003-11-19 2006-02-24 Inst Rech Developpement Ird Nouveaux moyens pour la prevention des leishmanioses
FR2863272B1 (fr) * 2003-11-19 2006-06-09 Inst Rech Developpement Ird Nouveaux moyens pour la prevention des leishmanioses
US20050176144A1 (en) * 2004-02-06 2005-08-11 O'daly Jose A. Culture media compositions free of fetal bovine serum
FR2881752B1 (fr) 2005-02-10 2009-07-31 Inst Rech Pour Le Dev I R D Et Moyens pour l'obtention de promastigotes de leishmanies avirulents, promastigotes obtenus et leurs applications
DE102006041388A1 (de) * 2006-08-29 2008-03-20 Fachhochschule Jena Nährmedium und Verfahren zur Kultivierung eines Protozoan zu hohen Zelldichten mit hohen spezifischen Wachstumsraten
FR3014103B1 (fr) 2013-11-29 2019-08-16 Institut De Recherche Pour Le Developpement (Ird) Composition vaccinale pour la prevention et/ou le traitement de leishmanioses, peptides immunogenes et procede d'obtention
FR3081870B1 (fr) 2018-05-30 2024-04-19 Institut De Rech Pour Le Developpement Ird Epitopes, composes peptidiques mono-ou multiepitopiques et vaccins contre la leishmanie
BR102018067339A2 (pt) 2018-08-31 2021-11-16 Fundação Oswaldo Cruz Método para detectar anticorpos contra leishmania em uma amostra biológica canina, kit para detecção de infecção por leishmania em uma amostra biológica, e uso de lipofosfoglicano de leishmania

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US399743A (en) * 1889-03-19 Peters
FR1518449A (fr) * 1967-04-12 1968-03-22 Vnii Antibiotikov Procédé de culture des leishmanies
US3911097A (en) * 1973-08-07 1975-10-07 Research Corp Antigenic preparation suitable for diagnosis of chronic chagas disease
US3993743A (en) * 1973-08-07 1976-11-23 Research Corporation Method for diagnosis of Chagas' disease
IL67295A0 (en) * 1981-11-17 1983-03-31 Brigham & Womens Hospital Monoclonal antibodies against leishmania
EP0197062B1 (de) * 1984-10-01 1991-01-09 Institut Pasteur Antileishmania monoklonale antikörper, diese antikörper ausscheidende hybridomas, von diesen antikörpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikörpern und antigenen
US4687666A (en) * 1985-02-19 1987-08-18 Ministerio De Sanidad Y Asistencia Social Instituto Venezolano De Investigationes Cientificas Vaccine for Leishmaniasis
GB8921937D0 (en) * 1989-09-28 1989-11-15 Howard Michael K Diagnostic reagents for leishmaniasis
JPH07504801A (ja) * 1991-08-06 1995-06-01 ザ　ワールド　ヘルス　オーガニゼイション Ｄｎａの単離方法
US5411865A (en) * 1993-01-15 1995-05-02 Iasys Corporation Method of detecting anti-leishmania parasite antibodies

Also Published As

Publication number Publication date
ES2245776T3 (es) 2006-01-16
EP0698099A1 (de) 1996-02-28
DE69434424D1 (de) 2005-08-18
CA2162555C (fr) 2011-07-12
FR11C0040I1 (de) 2011-10-14
FR11C0040I2 (fr) 2012-06-22
US20030138461A1 (en) 2003-07-24
US6458581B1 (en) 2002-10-01
US7317094B2 (en) 2008-01-08
FR2705358A1 (fr) 1994-11-25
US7282210B2 (en) 2007-10-16
DE69434424T2 (de) 2006-04-20
WO1994026899A1 (fr) 1994-11-24
FR2705358B1 (fr) 1995-08-04
AU6800094A (en) 1994-12-12
US20030068690A1 (en) 2003-04-10
EP0698099B1 (de) 2005-07-13
US20030059860A1 (en) 2003-03-27
CA2162555A1 (fr) 1994-11-24

Similar Documents

Publication Publication Date Title
DE122011100046I1 (de) In vitro kulturprozess fur verschiedene stadien von gewebeparasiten.
DE69007691T2 (de) Verfahren zur Herstellung von Alkylaluminoxanen.
DE69016590D1 (de) Verfahren zur Herstellung von Acrylsäure.
DE3874019D1 (de) Verfahren zur konservierung von transplantierbaren, in vitro kultivierten epithelgeweben.
DE69102552D1 (de) Verfahren zur Behandlung von Fasermaterialien.
DE69003009D1 (de) Verfahren zur Behandlung von Fasermaterialien.
DE69423179D1 (de) Prozess zur Herstellung von optisch aktiven 2-Amino-1-phenylethanol Derivaten
DE69126646T2 (de) Biologisches Verfahren zur Herstellung von optisch-aktiver Milchsäure
DE69023529T2 (de) Verfahren zur Behandlung von wässerigen Fermentationsbrühen.
DE69004501T2 (de) Materialbehandlungsverfahren.
DE69021711D1 (de) Verfahren zur Herstellung von optisch aktiven Hydroxylactonen.
DE59003447D1 (de) Verfahren zur Herstellung von Benztriazolen.
DE69018215D1 (de) Verfahren zur Produktion von optisch aktivem Atenolol und Zwischenprodukt davon.
DE59104247D1 (de) Verfahren zur Racemisierung von optisch aktiven 1-Aryl-alkylaminen.
DE69012304D1 (de) Einrichtung zur Augenbehandlung.
TR23818A (tr) Yueksek cikarimli kromla tabaklama islemi
DE59101189D1 (de) Verfahren zur Herstellung von Chinophthalonen.
DE69016693D1 (de) Züchtung von transformierten Mikroorganismen.
DE69410856D1 (de) Verfahren zur Herstellung von optisch aktiven Beta-hydroxy-ketonen
DE69019843D1 (de) Verfahren zur Herstellung von NADH-Oxydase.
DE69403497D1 (de) Verfahren zur Herstellung von optisch aktivem 2-Aminopropanal
BR8804961A (pt) Processo para cultura de plantas
DE69112236D1 (de) Verfahren zur mikrobiologischen Herstellung von Ironen.
DE69011065T2 (de) Verfahren zur Behandlung von Nickel-Magnesium-Silikaterzen.
DE59005150D1 (de) Verfahren zur stereoselektiven Herstellung von optisch aktiven S,S- oder R,R-beta-Aminoalkoholen.